Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 57, Issue 7


The search for a new test of early cancer detection

Maria D. Pasic
  • Corresponding author
  • Department of Laboratory Medicine, St. Joseph’s Health Centre, 30 The Queensway, Toronto, ON M6R 1B5, Canada
  • Department of Laboratory Medicine, St. Michael’s Hospital, Toronto, ON, Canada
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, Phone: (+416) 530-6263
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-11-28 | DOI: https://doi.org/10.1515/cclm-2018-1007


  • 1.

    Diamandis EP, Li M. The side effects of translational omics: overtesting, overdiagnosis, overtreatment. Clin Chem Lab Med 2016;54:389–96.Web of SciencePubMedGoogle Scholar

  • 2.

    Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Benton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 2017;17:223–38.Web of ScienceCrossrefPubMedGoogle Scholar

  • 3.

    Diamandis EP, Fiala C. Can circulating tumor DNA be used for direct and early stage cancer detection? F1000Res 2017;6:2129.CrossrefPubMedGoogle Scholar

  • 4.

    Aravanis AM, Lee M, Klausner RD. Next-generation sequencing of circulating tumor DNA for early cancer detection. Cell 2017;168:571–4.Web of ScienceCrossrefPubMedGoogle Scholar

  • 5.

    Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 2018;359:926–30.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 6.

    Liu MC, Maddala T, Aravanis A, Hubbel E, Beusang JF, Filippova D, et al. Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study. J Clin Oncol 2018;36(suppl: abstr536):12021.CrossrefWeb of ScienceGoogle Scholar

  • 7.

    Klein EA, Hubbel E, Maddala T, Aravanis A, Beusang JF, Filippova D, et al. Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell Free Genome Atlas (CCGA) study. J Clin Oncol 2018;36(suppl: abstr12021):536.Web of ScienceCrossrefGoogle Scholar

About the article

Corresponding author: Maria D. Pasic, PhD, FCACB, Department of Laboratory Medicine, St. Joseph’s Health Centre, 30 The Queensway, Toronto, ON M6R 1B5, Canada

Received: 2018-09-12

Accepted: 2018-10-13

Published Online: 2018-11-28

Published in Print: 2019-06-26

Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 7, Pages e139–e140, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-1007.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in